CMS Ground-Breaking Advancement in Diabetes Excellence Supported by Glytec Glucose Management Platform BOSTON , Aug. 5, 2024 /PRNewswire/ -- Glytec , the only provider of cloud-based insulin management Software as a Service (SaaS) and analytics solutions across the continuum of care, proudly supports CMS's new mandatory reporting requirements aimed at improving hyper- and hypoglycemia measures. This significant step advances diabetes excellence across the United States , particularly benefiting rural and underserved communities, and enhances broader value-based care initiatives.
CMS has noted: "We thank commenters for their support. We agree that modifications to eCQM reporting requirements to include patient safety outcome eCQMs would increase public reporting on quality and safety, thus empowering individuals to make decisions about where to go for care, which is one of our key actions to drive improvements in safety as outlined in the CMS National Quality Strategy." "We applaud CMS's move to mandate hyper- and hypoglycemia measures.
This initiative significantly advances diabetes excellence in the United States , particularly benefiting rural and underserved areas," said Patrick Cua , President and CEO at Glytec. "We anticipate that State Medicaid and Commercial Health Plans will adopt similar measures, and with our 18 years of experience and FDA-cleared solutions, we are ready to assist hospitals and communities in implementing and maintaining these critical diabetes mana.